Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -22.15% is 31% above its 5-year average of -32.25%, near the high end of its 5-year range (-48.10%–-13.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.27% above its 12-month average of -29.24%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -22.15%.
RETURN ON INVESTED CAPITAL (ROIC)
-22.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-29.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-32.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-32.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.27%
CURRENT VS 3Y AVG
+31.77%
CURRENT VS 5Y AVG
+31.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+37.87%
vs the sector median at left
Neuronetics, Inc.
Market Cap
$154.14M
Return on Invested Capital (ROIC)
-22.15%
TTM Avg
-29.24%
3Y Avg
-32.46%
5Y Avg
-32.25%
Market Cap
$154.79M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$152.82M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-138.87%
3Y Avg
-97.17%
5Y Avg
-81.85%
Market Cap
$157.01M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-16.11%
3Y Avg
-25.11%
5Y Avg
-17.04%
Market Cap
$149.28M
Return on Invested Capital (ROIC)
-165.56%
TTM Avg
-176.54%
3Y Avg
-127.81%
5Y Avg
-112.12%
Market Cap
$148.97M
Return on Invested Capital (ROIC)
-23.41%
TTM Avg
-38.99%
3Y Avg
-40.72%
5Y Avg
-30.95%
Market Cap
$148.57M
Return on Invested Capital (ROIC)
-27.25%
TTM Avg
-49.08%
3Y Avg
-43.31%
5Y Avg
-52.54%
Market Cap
$148.71M
Return on Invested Capital (ROIC)
-223.90%
TTM Avg
-825.42%
3Y Avg
-606.12%
5Y Avg
-416.73%
Market Cap
$148.64M
Return on Invested Capital (ROIC)
-56.53%
TTM Avg
-185.89%
3Y Avg
-125.01%
5Y Avg
-88.85%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuronetics, Inc. (STIM) | $154.14M | -22.15% | -29.24% | -32.46% | -32.25% |
| LifeMD, Inc. (LFMDP)vs › | $154.79M | -143.97% | -52.39% | -55.03% | -91.26% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | N/A | -138.87% | -97.17% | -81.85% |
| Inogen, Inc. (INGN)vs › | $157.01M | -13.94% | -16.11% | -25.11% | -17.04% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $149.28M | -165.56% | -176.54% | -127.81% | -112.12% |
| Codexis, Inc. (CDXS)vs › | $148.97M | -23.41% | -38.99% | -40.72% | -30.95% |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.57M | -27.25% | -49.08% | -43.31% | -52.54% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.71M | -223.90% | -825.42% | -606.12% | -416.73% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $148.64M | -56.53% | -185.89% | -125.01% | -88.85% |
| PepGen Inc. (PEPG)vs › | $159.71M | -57.59% | -65.44% | -58.20% | -45.38% |
ROIC
-22.1%
ROE
-170.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -22.15% |
| 2026-03-31 | -30.28% |
| 2025-12-31 | -26.96% |
| 2025-09-30 | -31.01% |
| 2025-06-30 | -35.82% |
| 2025-03-31 | -33.05% |
| 2024-12-31 | -31.53% |
| 2024-09-30 | -48.10% |
| 2024-06-30 | -35.31% |
| 2024-03-31 | -30.80% |
| 2023-12-31 | -31.82% |
| 2023-09-30 | -43.60% |
| 2023-06-30 | -38.00% |
| 2023-03-31 | -39.43% |
| 2022-12-31 | -36.27% |
| 2022-09-30 | -33.35% |
| 2022-06-30 | -31.39% |
| 2022-03-31 | -26.37% |
| 2021-12-31 | -21.96% |
| 2021-09-30 | -17.88% |
| 2021-06-30 | -13.59% |
| 2021-03-31 | -13.33% |
| 2020-12-31 | -34.33% |
| 2020-09-30 | -39.62% |
| 2020-06-30 | -44.18% |
| 2020-03-31 | -39.75% |
| 2019-12-31 | -32.16% |
| 2019-09-30 | -28.03% |
| 2019-06-30 | -24.37% |
| 2019-03-31 | -21.94% |
| 2018-12-31 | -19.17% |
| 2018-09-30 | -16.94% |
| 2018-06-30 | -105.53% |
| 2018-03-31 | -65.36% |
| 2017-12-31 | -50.50% |
